Dorie E Apollonio

ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 22

Top Venues

BMC public health

Clinical toxicology (Philadelphia, Pa.)

BMJ open

Tobacco control

University of California, San Francisco

University of California Berkeley (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of California, San Francisco Oct 01 2006

United States

Professor :: Clinical Pharmacy

Education History

University of California Berkeley

United States

PHD

Publications

Christie Lee, Allison Tsui, Selina Xu, Dorie E Apollonio
Evaluation of the strategies opioid manufacturers used to recruit health professionals and encourage overprescribing: an analysis of industry documents. BMC public health 24 (1) (2024)
Christie Lee, Allison Tsui, Selina Xu, Dorie E Apollonio
Evaluation of the strategies opioid manufacturers used to recruit health professionals and encourage overprescribing: an analysis of industry documents. BMC public health 24 (1) (2024)
Joana Orta, Catherine Barton, Patricia Ilao, Dorie E Apollonio
A review of policies on the involuntary use of psychotropic medications among persons experiencing incarceration in the United States. Health & justice 11 (1) (2023)
Joana Orta, Catherine Barton, Patricia Ilao, Dorie E Apollonio
A review of policies on the involuntary use of psychotropic medications among persons experiencing incarceration in the United States. Health & justice 11 (1) (2023)
Gea De Los Reyes, Amena Ng, Jazmin Valencia Chavez, Dorie E Apollonio, Lisa Kroon, Phoebe Lee, Maya Vijayaraghavan
Evaluation of a Pharmacist-Linked Smoking Cessation Intervention for Adults Experiencing Homelessness. Substance use & misuse (2023)
Alice Ghai, Emily Sabour, Raeann Salonga, Raymond Ho, Dorie E Apollonio
Exposures to Bleach, Peroxide, Disinfectants, Antimalarials, and Ivermectin Reported to the California Poison Control System Before and During the COVID-19 Pandemic, 2015-2021. Public health reports (Washington, D.C. : 1974) (2023)
Joana Orta, Catherine Barton, Patricia Ilao, Dorie E Apollonio
A review of policies on the involuntary use of psychotropic medications among persons experiencing incarceration in the United States. Health & justice 11 (1) (2023)
Tanner D Wakefield, Jamie Guillory, Pamela M Ling, Dorie E Apollonio
Descriptive cross-sectional survey of tobacco and cannabis restrictions on state and local film incentives in the USA. Tobacco control (2023)
Emily Chu, Gina Cocos, Ho Jun Lee, Jane Go, Justin Lewis, Dorie E Apollonio
Trends in concomitant and single opioid and benzodiazepine exposures reported to the California Poison Control System following the Centers for Disease Control and Prevention release of opioid guidelines in 2016. Clinical toxicology (Philadelphia, Pa.) (2023)
Dorie E Apollonio
Marketing Antipsychotics to Correctional Facilities: A Review of Pharmaceutical Industry Documents. Journal of correctional health care : the official journal of the National Commission on Correctional Health Care 28 (5) (2022)
Hanna Yakubi, Brian Gac, Dorie E Apollonio
Industry strategies to market opioids to children and women in the USA: a content analysis of internal industry documents from 1999 to 2017 released in State of Oklahoma v. Purdue Pharma, L.P. et al . BMJ open 12 (11) (2022)
Zachary Carlson, Steven Pham, Jackie El-Sokkary, Dorie E Apollonio
Cannabis use prevalence among Baby Boomers before and after implementation of recreational retail sales in California. Substance abuse treatment, prevention, and policy 17 (1) (2022)
Dorie E Apollonio, Lauren M Dutra, Stanton A Glantz
Associations between smoking trajectories, smoke-free laws and cigarette taxes in a longitudinal sample of youth and young adults. PloS one 16 (2) (2021)
Winter Roth, Mitchell Tam, Carrie Bi, June Kim, Justin Lewis, Raymond Ho, Dorie E Apollonio
Changes in California cannabis exposures following recreational legalization and the COVID-19 pandemic. Clinical toxicology (Philadelphia, Pa.) (2021)
Gabrielle Driller, Emily Plasencia, Dorie E Apollonio
Retrospective review of nicotine exposures in California from 2012 to 2018 and analysis of the impacts of e-cigarette regulations. BMJ open 11 (3) (2021)
Sarah V Pasetes, Pamela M Ling, Dorie E Apollonio
Cognitive performance effects of nicotine and industry affiliation: a systematic review. Substance abuse : research and treatment 14 (2020)
Dorie E Apollonio, Stanton A Glantz
Tobacco manufacturer lobbying to undercut minimum price laws: an analysis of internal industry documents. Tobacco control 29 (e1) (2020)
Alice Wu, Christine Phan, Kim Chi Nguyen, Melvin Quindoy, Justin Lewis, Dorie E Apollonio
Trends in hydrocodone combination product exposures reported to California Poison Control System (CPCS) following DEA rescheduling. Clinical toxicology (Philadelphia, Pa.) 59 (4) (2020)
Liriany Pimentel, Dorie E Apollonio
Placement and sales of tobacco products and nicotine replacement therapy in tobacco-free and tobacco-selling pharmacies in Northern California: an observational study. BMJ open 9 (6) (2019)
Dorie E Apollonio, Stanton A Glantz
Marketing with tobacco pack onserts: a qualitative analysis of tobacco industry documents. Tobacco control 28 (3) (2018)
Jocelyn Huey, Dorie E Apollonio
A content analysis of popular media reporting regarding increases in minimum ages of legal access for tobacco. BMC public health 18 (1) (2018)
Dorie E Apollonio, Nicole Wolfe, Lisa A Bero
Realist review of policy intervention studies aimed at reducing exposures to environmental hazards in the United States. BMC public health 16 (1) (2016)

Dorie E Apollonio.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Dorie E Apollonio